Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Dec 3;129(12):1102-1104.
doi: 10.1161/CIRCRESAHA.121.320328. Epub 2021 Dec 2.

Resident Macrophages in the Heart: Cardioprotective Under Pressure

Affiliations
Editorial

Resident Macrophages in the Heart: Cardioprotective Under Pressure

Mohamed Ameen Ismahil et al. Circ Res. .
No abstract available

Keywords: Editorials; fibrosis; heart failure; macrophages; monocytes; ventricular remodeling.

PubMed Disclaimer

Figures

Figure
Figure. Resident macrophages (M∅s) in the pressure-overloaded heart.
Early (1 week) after the imposition of pressure overload via transverse aortic constriction (TAC) in the mouse heart, there is significant expansion of both CCR2 resident M∅s (multiple subpopulations) and CCR2+ monocyte-derived M∅s. These two M∅ populations exert differential and opposing effects on cardiac remodeling - resident M∅s induce antifibrotic and pro-angiogenic responses that counteract the tissue injurious and pro-inflammatory responses mediated by monocyte-derived M∅s. Preferential resident M∅ depletion using a CD115 blocking antibody prior to TAC disrupts this balance to promote fibrosis, microvascular rarefaction, late adverse remodeling and heart failure. Schema based on the study by Revelo et al (19)

Comment on

References

    1. Hunter JJ and Chien KR. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med. 1999;341:1276–83. - PubMed
    1. Xia Y, Lee K, Li N, Corbett D, Mendoza L and Frangogiannis NG. Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. Histochem Cell Biol. 2009;131:471–81. - PMC - PubMed
    1. Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, Bauer EP, Klovekorn WP and Schaper J. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003;107:984–91. - PubMed
    1. Trenson S, Hermans H, Craps S, Pokreisz P, de Zeeuw P, Van Wauwe J, Gillijns H, Veltman D, Wei F, Caluwe E, Gijsbers R, Baatsen P, Staessen JA, Ghesquiere B, Carmeliet P, Rega F, Meuris B, Meyns B, Oosterlinck W, Duchenne J, Goetschalckx K, Voigt JU, Herregods MC, Herijgers P, Luttun A and Janssens S. Cardiac Microvascular Endothelial Cells in Pressure Overload-Induced Heart Disease. Circ Heart Fail. 2021;14:e006979. - PubMed
    1. Levy D, Garrison RJ, Savage DD, Kannel WB and Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561–6. - PubMed